Eveline M. De Bont
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 23, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
Journal: Cancers
Published: February 22, 2024
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.
Journal: Frontiers in pharmacology
Published: September 13, 2022
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.
Journal: Frontiers in pharmacology
Published: June 28, 2022
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.
Journal: Proteomics. Clinical applications
Published: August 20, 2021
CREB signaling activity correlates with differentiation and survival in medulloblastoma.
Journal: Scientific reports
Published: September 15, 2020
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 09, 2020
Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
Journal: Expert review of proteomics
Published: January 17, 2020
Social competence in newly diagnosed pediatric brain tumor patients.
Journal: Pediatric hematology and oncology
Published: November 05, 2019
Last Updated: 09/26/2026